Main Menu

Joint Sarcoma Research Centre

We have been driving pioneering research for innovative treatments for sarcomas since our launch in January 2019. We're a virtual research centre and a collaboration between the Institute of Cancer Research and The Royal Marsden NHS Foundation Trust.

Alveola Soft Part Sarcoma

What are sarcomas 

Sarcomas are a group of more than 100 different rare cancer types that affect connective tissue, such as muscle and fat.

Who do sarcomas affect 

Sarcomas represent one per cent of cancers in adults, but 15 per cent of cancers in children and young people – and they are associated with considerable morbidity and mortality. Survival rates haven’t improved in decades, so there is a pressing need to develop new treatment and individualised therapy.

Our research into sarcomas

The Joint Sarcoma Research Centre includes scientists and clinicians who are active in sarcoma research across our two organisations. Our co-directors are:

Our Deputy Director is Dr Paul Huang, leader of the ICR's Molecular and Systems Oncology Team.

Scientific aims and themes

The centre brings together the breadth of clinical, translational and preclinical sarcoma research being undertaken to lead a coordinated research strategy that will make a major clinical impact nationally and internationally.

Find out more about our research

Core investigators

Investigators at our Joint Sarcoma Research Centre are senior researchers from both the ICR and The Royal Marsden. We are a virtual centre that encompasses all research on sarcoma from our two institutions.

Meet our team of investigators

Sarcoma Accelerator Consortium

Our five-year project - the Sarcoma Accelerator Consortium - is a digital hub that will help us predict and test patient responses to drugs for high-risk sarcomas using artificial intelligence.

Find out more about the Consortium